For example, in Multiple Myeloma (MM), a plasma cell malignancy developing in the BM, TCs have increased RANKL and decreased OPG expression, resulting in enhanced OC bone resorption and the development of lytic bone lesions (93). This evidence concerns the gene TNFSF11 and Miyoshi myopathy.